NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹2.59 Cr | ₹-8.72 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NEULAND LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹44 Cr |
Mar2024 | ₹42 Cr |
Mar2023 | ₹40 Cr |
Mar2022 | ₹2.59 Cr |
Mar2021 | ₹-8.72 Cr |
How is Net Cash Inflow / Outflow of NEULAND LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹44 Cr | 4.69 | |
Mar2024 | ₹42 Cr | 5.74 | |
Mar2023 | ₹40 Cr | 1,438.86 | |
Mar2022 | ₹2.59 Cr | Positive | |
Mar2021 | ₹-8.72 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,655.0 Cr | -3.2% | 14.8% | 70% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,720.0 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -3.2% |
14.8% |
70% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses